Registry Study on "Control Nocturnal Hypertension to Reach the Target " (CONTROL-NHT)

Shanghai Institute of Hypertension

Status: Enrolling

Conditions: Nocturnal Hypertension

Study type: Observational

Funder types: Other

Identifiers

NCT04137549

CONTROL-NHT

Details and patient eligibility

About

Ambulatory blood pressure monitoring (ABPM) is a major innovation in the history of hypertension diagnosis. In clinical practice, the most well established indication for using ABPM is to identify patients who have high BP readings in the office but normal readings during usual daily activities outside of this setting or vice versa, and to identify varying 24-h BP profiles. However, in recent years, there has been increasing interest in BP values during sleep, and nocturnal BP is now recognized to be superior to daytime BP in predicting fatal and nonfatal cardiovascular events (stroke, myocardial infarction, and cardiovascular death), especially in medicated patients.

The current direction in the management of hypertension is toward earlier and lower BP control for 24 hours, including the nocturnal and morning periods. Therefore, it may be of great significance to pay attention to the management of nocturnal blood pressure so as to reduce the increased cardiovascular risks.

Information of nocturnal hypertensive patients defined by ABPM was prospectively registered nationwide, and then to investigate whether there was difference in cardiovascular prognosis according to the control of ambulatory nocturnal blood pressure.

Enrollment: 4,500 estimated patients

Sex: All

Ages: 50 to 79 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 50-79 years old
• Clinical diagnosed hypertension with the use of antihypertensive drugs
• Nocturnal hypertension ( nocturnal systolic blood pressure ≥ 130 mmHg and/or nocturnal diastolic blood pressure ≥ 80 mmHg)
• A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
• Willing to provide information about disease history and blood biochemical test data within 6 months.
• Sign the informed consent

Exclusion criteria

• Without antihypertensive drug use
• Hospitalized hypertension patients
• Non-compliant patient

Trial design

4,500 participants in 2 patient groups

Nocturnal controlled hypertension

Description:

Nocturnal blood pressure was controlled under 120/70 mmHg after aggressive anti-hypertensive therapy.

Nocturnal uncontrolled hypertension

Description:

Nocturnal blood pressure was still over 120/70 mmHg after aggressive anti-hypertensive therapy.